Original Research
Accepted on 15 May 2025
Cord Blood-Derived, Engineered Invariant Natural Killer T Cells as a Platform for Allogeneic
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 May 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 May 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 May 2025
in Digital Manufacturing
Original Research
Accepted on 15 May 2025
in Earthquake Engineering
Original Research
Accepted on 15 May 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 May 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 15 May 2025
in Ethnopharmacology
Review
Accepted on 15 May 2025
in Ethnopharmacology
Original Research
Accepted on 15 May 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 May 2025
in Cardiovascular Surgery
Original Research
Accepted on 15 May 2025
in Translational Medicine
Review
Accepted on 15 May 2025
in Molecular Innate Immunity
Original Research
Accepted on 15 May 2025
in Renal Endocrinology
Original Research
Accepted on 15 May 2025
in Molecular Innate Immunity
Case Report
Accepted on 15 May 2025
in Pediatric Oncology
Perspective
Accepted on 15 May 2025
in Cancer Immunity and Immunotherapy